Endocrinology, Vol 137, 3193-3199, Copyright © 1996 by Endocrine Society

ARTICLES

Glucagon response to hypoglycemia is improved by insulin-independent restoration of normoglycemia in diabetic rats

ZQ Shi, KS Rastogi, M Lekas, S Efendic, DJ Drucker and M Vranic
Department of Physiology, Faculty of Medicine, University of Toronto, Ontario, Canada.

The aim of this study was to determine whether the impaired glucagon response to insulin-induced hypoglycemia in the diabetic rat can be improved by correction of hyperglycemia independent of insulin. Four groups of age-matched male Sprague-Dawley rats (246 +/- 13 g BW) were studied: 1) normal controls (NC; n = 7); 2) diabetic, untreated (DU; n = 6); 3) diabetic, treated for 5-7 days using sustained release (2-3 U/day) insulin implants (DI; n = 6); and 4) diabetic, treated for 3-4 days with phlorizin (0.4 g/kg), given sc twice daily (DP; n = 7). Diabetes was induced by a single injection of streptozotocin (65 mg/kg). Basal plasma glucose was 7.4 +/- 0.3 mM in NC, but rose to 14.5 +/- 2.2 mM in DU. Basal hyperglycemia was corrected with phlorizin and insulin treatments (5.5 +/- 0.5 and 6.7 +/- 0.8 mM, respectively). NC rats responded to insulin-induced hypoglycemia with a rapid and marked increase in glucagon (peak, 2059 +/- 311 pg/ml). The glucagon response was blunted in DU (635 +/- 180 pg/ml) and was partially improved by prolonged normalization of glycemia in DP (1335 +/- 295 pg/ml; P < 0.05). Plasma somatostatin levels in all diabetic groups were 2- to 3- fold higher in the basal state, but were not different during hypoglycemia, than those in NC rats. Compared to levels in NC rats, diabetes resulted in decreased insulin, but elevated glucagon and somatostatin concentrations in the pancreatic tissue. Treatment with both insulin and phlorizin reversed the changes in the pancreatic content of both glucagon and somatostatin. Pancreatic proglucagon messenger RNA did not show significant differences among the four groups in either state. Insulin treatment in the DI group resulted in a delayed and much smaller increase in the glucagon response (740 +/- 138 pg/ml) to hypoglycemia despite normalization of glycemia. We, therefore, conclude that in streptozotocin-diabetic rats, the impaired glucagon responsiveness to hypoglycemia is significantly improved by insulin-independent correction of hyperglycemia, suggesting the importance of normoglycemia per se in maintaining, at least in part, the glucose sensitivity of pancreatic alpha-cells.

This article has been cited by other articles:

				S. Han, D. L. Hagan, J. R. Taylor, L. Xin, W. Meng, S. A. Biller, J. R. Wetterau, W. N. Washburn, and J. M. Whaley Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats Diabetes, June 1, 2008; 57(6): 1723 - 1729. [Abstract] [Full Text] [PDF]

				K. E. Inouye, J. T. Y. Yue, O. Chan, T. Kim, E. M. Akirav, E. Park, M. C. Riddell, E. Burdett, S. G. Matthews, and M. Vranic Effects of Insulin Treatment without and with Recurrent Hypoglycemia on Hypoglycemic Counterregulation and Adrenal Catecholamine-Synthesizing Enzymes in Diabetic Rats Endocrinology, April 1, 2006; 147(4): 1860 - 1870. [Abstract] [Full Text] [PDF]

				E. Park, O. Chan, Q. Li, M. Kiraly, S. G. Matthews, M. Vranic, and M. C. Riddell Changes in basal hypothalamo-pituitary-adrenal activity during exercise training are centrally mediated Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1360 - R1371. [Abstract] [Full Text] [PDF]

				R. McGirr, C. E. Ejbick, D. E. Carter, J. D. Andrews, Y. Nie, T. C. Friedman, and S. Dhanvantari Glucose Dependence of the Regulated Secretory Pathway in {alpha}TC1-6 Cells Endocrinology, October 1, 2005; 146(10): 4514 - 4523. [Abstract] [Full Text] [PDF]

				E. Bertelli and M. Bendayan Association between Endocrine Pancreas and Ductal System. More than an Epiphenomenon of Endocrine Differentiation and Development? J. Histochem. Cytochem., September 1, 2005; 53(9): 1071 - 1086. [Abstract] [Full Text] [PDF]

				O. Chan, K. Inouye, E. M. Akirav, E. Park, M. C. Riddell, S. G. Matthews, and M. Vranic Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R235 - R246. [Abstract] [Full Text] [PDF]

				O. Chan, K. Inouye, E. Akirav, E. Park, M. C. Riddell, M. Vranic, and S. G. Matthews Insulin Alone Increases Hypothalamo-Pituitary-Adrenal Activity, and Diabetes Lowers Peak Stress Responses Endocrinology, March 1, 2005; 146(3): 1382 - 1390. [Abstract] [Full Text] [PDF]

				K. M. Hope, P. O. T. Tran, H. Zhou, E. Oseid, E. Leroy, and R. P. Robertson Regulation of {alpha}-Cell Function by the {beta}-Cell in Isolated Human and Rat Islets Deprived of Glucose: the "Switch-off" Hypothesis Diabetes, June 1, 2004; 53(6): 1488 - 1495. [Abstract] [Full Text] [PDF]

				T. O. Mundinger, Q. Mei, D. P. Figlewicz, A. Lernmark, and G. J. Taborsky Jr Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1047 - E1054. [Abstract] [Full Text] [PDF]

				R. J. McCrimmon, M. L. Evans, R. J. Jacob, X. Fan, Y. Zhu, G. I. Shulman, and R. S. Sherwin AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1076 - E1083. [Abstract] [Full Text] [PDF]

				O. Chan, S. Chan, K. Inouye, K. Shum, S. G. Matthews, and M. Vranic Diabetes Impairs Hypothalamo-Pituitary-Adrenal (HPA) Responses to Hypoglycemia, and Insulin Treatment Normalizes HPA but not Epinephrine Responses Diabetes, June 1, 2002; 51(6): 1681 - 1689. [Abstract] [Full Text] [PDF]

				E. Dumonteil, B. Ritz-Laser, C. Magnan, I. Grigorescu, A. Ktorza, and J. Philippe Chronic Exposure to High Glucose Concentrations Increases Proglucagon Messenger Ribonucleic Acid Levels and Glucagon Release from InR1G9 Cells Endocrinology, October 1, 1999; 140(10): 4644 - 4650. [Abstract] [Full Text]

				G. F. Lewis, A. Carpentier, D. Bilinski, A. Giacca, and M. Vranic Counterregulatory Response to Hypoglycemia Differs According to the Insulin Delivery Route, But Does Not Affect Glucose Production in Normal Humans J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1037 - 1046. [Abstract] [Full Text]

				E. Dumonteil, C. Magnan, B. Ritz-Laser, P. Meda, P. Dussoix, M. Gilbert, A. Ktorza, and J. Philippe Insulin, But Not Glucose Lowering Corrects the Hyperglucagonemia and Increased Proglucagon Messenger Ribonucleic Acid Levels Observed in Insulinopenic Diabetes Endocrinology, November 1, 1998; 139(11): 4540 - 4546. [Abstract] [Full Text] [PDF]